A comparative study between dexmedetomidne and magnesium sulphate when added with ropivacaine for brachial plexus block in hand surgeries

ULTRASOUND GUIDED AXILLARY APPROACH TO BRACHIAL PLEXUS FOR HAND SURGRIES COMPARISION OF MAGNESIUM SULPHATE AND DEXMEDETOMIDINE AS ADJUVANTS TO ROPIVACAINE - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/03/063571

Enrollment

Registered

2024-03-04

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: W01- Fall on same level from slipping,tripping and stumbling Health Condition 2: O- Medical and Surgical

Interventions

Intervention1: dexmedetomidine 30 mcg: Adding of 30 mcg dexmedetomidine to 0.5% ropivacaine for axillary brachial plexus block for hand surgeries, for upto 12 hrs Control Intervention1: magnesium sulp

Eligibility

Inclusion criteria

Inclusion criteria: Patients undergoing hand surgeries ASA 1 & 2

Exclusion criteria

Exclusion criteria: Patients with Co-existing severe cardiovascular respiratory or neurological disorders Patients with any known history of coagulation disorders and inflammatory and infective skin lesions at the site of block Pre-existing neuropathies and allergy to local anaesthetics

Design outcomes

Primary

Measure	Time frame
Primary objective is to compare onset and duration of sensory and motor blockadeTimepoint: 5 mins 10 mins 15 mins 30 mins 1 hour 2 hours 6 hours 12 hours	—

Secondary

Measure	Time frame
Secondary objective is to compare hemodynamic changes, Time for requirement of rescue analgesia and adverse effects in both groupsTimepoint: 5 mins 10 mins 15 mins 30 mins 1 hour 2 hours 6 hours 12 hours	—

Countries

India

Contacts

Public ContactDr Nagella Jagadeesh Babu

Government Medical College Kadapa

mansoormohammed473@gmail.com9949706329

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026